Article

New insights: Experts discuss the value of SWEPT Source OCT technology in biometry

Download Article

ZEISS IOLMaster 700  

 

 

Renowned experts from all around the world met during the ESCRS 2016 to discuss their clinical experience with the ZEISS IOLMaster 700.

Read what they had to say about

  • Macular scans

  • Success rate of measurements

  • Integration into the clinical workflow

  • Fixation Check

Download Article

     

Contact ZEISS

×

Please fill out this form and you’ll receive an email with a link to download the article.

 

 

 

 

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Subscribe Now!
Related Videos
(Image credit: Ophthalmology Times) NeuroOp Guru: Using OCT to forecast outcomes in ethambutol optic neuropathy
(Image credit: Ophthalmology Times) Inside NYEE’s new refractive solutions center with Kira Manusis, MD
(Image credit: Ophthalmology Times) Dilsher Dhoot, MD, on the evolution of geographic atrophy therapy: where are we now?
(Image credit: Ophthalmology Times Europe) Anat Loewenstein, MD, shares insights on the real-world results of remote retinal imaging
(Image credit: Ophthalmology Times) Two-wavelength autofluorescence for macular xanthophyll carotenoids with Christine Curcio, PhD
(Image credit: Ophthalmology Times) FLIO and the brain: Making the invisible visible with Robert Sergott, MD
(Image credit: Ophthalmology Times) Structure-function correlates using high-res OCT images with Karl Csaky, MD, PhD
(Image credit: Ophthalmology Times) SriniVas Sadda, MD, on high-res OCT of atrophic and precursor lesions in AMD
(Image credit: Ophthalmology Times) Christine Curcio, PhD, shares histology update supporting review software and revised nomenclature for <3 μm OCT
Related Content
Most patients support AI in healthcare if it means more time with doctors
June 30th 2025

Most patients support AI in healthcare if it means more time with doctors

3 Things You Should Know About the GA Pipeline
June 4th 2025

3 Things You Should Know About Interventional Glaucoma Comanagement

Sanaregen Vision Therapeutics invites prospective investors to reserve stock shares
June 29th 2025

Sanaregen Vision Therapeutics invites prospective investors to reserve stock shares

Patient-Centered Treatment Strategies in the Management of nAMD and DME
May 30th 2025

Patient-Centered Treatment Strategies in the Management of nAMD and DME

PYC to finalize registrational study for RP11 after positive FDA feedback
June 28th 2025

PYC to finalize registrational study for RP11 after positive FDA feedback

Iridex enrolls first patient in study evaluating MicroPulse technology as an adjunct to anti-VEGF therapy for DME
June 28th 2025

Iridex enrolls first patient in study evaluating MicroPulse technology as an adjunct to anti-VEGF therapy for DME

© 2025 MJH Life Sciences

All rights reserved.